Clinical Trial Update: Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects [Phase 3]

View source ↗

Summary

Phase 3 study evaluating on-demand treatment with Xyntha (recombinant coagulation factor VIII) in Chinese subjects has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Xyntha (recombinant coagulation factor VIII)

Snippet

Sponsor: Pfizer | Conditions: Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2011-02-08